BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 15853918)

  • 21. Metabolism of tumour-derived urokinase receptor and receptor fragments in cancer patients and xenografted mice.
    Sier CF; Nicoletti I; Santovito ML; Frandsen T; Aletti G; Ferrari A; Lissoni A; Giavazzi R; Blasi F; Sidenius N
    Thromb Haemost; 2004 Feb; 91(2):403-11. PubMed ID: 14961171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of hormones on uPA, PAI-1 and suPAR from cultured endometrial and ovarian endometriotic stromal cells.
    Guan YM; Carlberg M; Bruse C; Carlström K; Bergqvist A
    Acta Obstet Gynecol Scand; 2002 May; 81(5):389-97. PubMed ID: 12027810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of urokinase plasminogen activator receptor and its cleaved forms in blood from patients with non-small cell lung cancer.
    Almasi CE; Høyer-Hansen G; Christensen IJ; Pappot H
    APMIS; 2009 Oct; 117(10):755-61. PubMed ID: 19775344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis.
    Shariat SF; Roehrborn CG; McConnell JD; Park S; Alam N; Wheeler TM; Slawin KM
    J Clin Oncol; 2007 Feb; 25(4):349-55. PubMed ID: 17264329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiency.
    Fevang B; Eugen-Olsen J; Yndestad A; Brosstad F; Beiske K; Aukrust P; Frøland SS
    Clin Immunol; 2009 Jun; 131(3):438-46. PubMed ID: 19232508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H; Wetterö J; Skogh T; Sjöwall C
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo activity of the cleaved form of soluble urokinase receptor: a new hematopoietic stem/progenitor cell mobilizer.
    Selleri C; Montuori N; Ricci P; Visconte V; Baiano A; Carriero MV; Rotoli B; Rossi G; Ragno P
    Cancer Res; 2006 Nov; 66(22):10885-90. PubMed ID: 17108125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum levels of soluble urokinase plasminogen activator receptor is associated with parasitemia in children with acute Plasmodium falciparum malaria infection.
    Perch M; Kofoed P; Fischer TK; Có F; Rombo L; Aaby P; Eugen-Olsen J
    Parasite Immunol; 2004 May; 26(5):207-11. PubMed ID: 15491469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blast cell-surface and plasma soluble urokinase receptor in acute leukemia patients: relationship to classification and response to therapy.
    Mustjoki S; Alitalo R; Stephens RW; Vaheri A
    Thromb Haemost; 1999 May; 81(5):705-10. PubMed ID: 10365741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of soluble urokinase plasminogen activator receptor in serum and cytosol of tumor tissue from patients with primary breast cancer.
    Riisbro R; Christensen IJ; Piironen T; Greenall M; Larsen B; Stephens RW; Han C; Høyer-Hansen G; Smith K; Brünner N; Harris AL
    Clin Cancer Res; 2002 May; 8(5):1132-41. PubMed ID: 12006529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urokinase-type plasminogen activator, receptor, and inhibitor correlating with gelatinase-B (MMP-9) contribute to inflammation in gouty arthritis of the knee.
    Chu SC; Yang SF; Lue KH; Hsieh YS; Hsiao TY; Lu KH
    J Rheumatol; 2006 Feb; 33(2):311-7. PubMed ID: 16465663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Release of soluble urokinase receptor from vascular cells.
    Chavakis T; Willuweit AK; Lupu F; Preissner KT; Kanse SM
    Thromb Haemost; 2001 Aug; 86(2):686-93. PubMed ID: 11522023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of urokinase-type plasminogen activator (uPA)/uPA receptor in HIV-1 infection.
    Alfano M; Sidenius N; Blasi F; Poli G
    J Leukoc Biol; 2003 Nov; 74(5):750-6. PubMed ID: 12960238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau.
    Eugen-Olsen J; Gustafson P; Sidenius N; Fischer TK; Parner J; Aaby P; Gomes VF; Lisse I
    Int J Tuberc Lung Dis; 2002 Aug; 6(8):686-92. PubMed ID: 12150480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis.
    Zimmermann HW; Koch A; Seidler S; Trautwein C; Tacke F
    Liver Int; 2012 Mar; 32(3):500-9. PubMed ID: 22098627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of cerebrospinal fluid uPA, PAI-1, and soluble uPAR levels in HIV-infected patients.
    Sporer B; Koedel U; Popp B; Paul R; Pfister HW
    J Neuroimmunol; 2005 Jun; 163(1-2):190-4. PubMed ID: 15885322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance.
    Sier CF; Sidenius N; Mariani A; Aletti G; Agape V; Ferrari A; Casetta G; Stephens RW; Brünner N; Blasi F
    Lab Invest; 1999 Jun; 79(6):717-22. PubMed ID: 10378514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma concentrations of soluble urokinase-type plasminogen activator receptor are increased in patients with malaria and are associated with a poor clinical or a fatal outcome.
    Ostrowski SR; Ullum H; Goka BQ; Høyer-Hansen G; Obeng-Adjei G; Pedersen BK; Akanmori BD; Kurtzhals JA
    J Infect Dis; 2005 Apr; 191(8):1331-41. PubMed ID: 15776381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crystallization of soluble urokinase receptor (suPAR) in complex with urokinase amino-terminal fragment (1-143).
    Huang M; Mazar AP; Parry G; Higazi AA; Kuo A; Cines DB
    Acta Crystallogr D Biol Crystallogr; 2005 Jun; 61(Pt 6):697-700. PubMed ID: 15930623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression of urokinase-type plasminogen activator and its receptor in plasma of patients with cerebral infarction].
    Song SJ; Hu JB; Wang HX; Wen SQ; Ding MP; Huang JZ
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(18):1583-5. PubMed ID: 14642114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.